NYSE · COTY

COTY Inc.

$2.72 +$0.07 (+2.64%) 1D After hours

Key Metrics

$2.33B
Market cap
P/E · TTM
$5.79B
Revenue · TTM
−$532.60M
Net income
EPS · TTM $-0.61
Dividend yield
Free cash flow $310.50M
Beta · 1Y 0.75
EBITDA · TTM
Gross margin 63.2%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 30
    The stock moved +10.2% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 30
  • Jun 4
    From its Feb 4 high, the share price fell 46%.

    Peak close $3.43 on Feb 4; trough close $1.85 on Jun 4. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -46%
  • Feb 6
    The stock moved -15.6% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 6

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$2.33B
Enterprise value$5.25B
Shares outstanding880.5M
52-wk range$1.82 – $5.15
Avg volume · 20D7.3M
Net cash −$2.91B
Book value / share$3.53
IndustryPerfumes, Cosmetics & Other Toilet Preparations
ExchangeNYSE
About COTY Inc.
IPO dateJun 13, 2013
Employees11636

Coty is a global beauty maker that generates 65% of sales from prestige beauty products (primarily fragrances) and 35% from mass makeup, skin care, and fragrance. For the fragrance business, Coty licenses luxury and high-end brands including Gucci, Burberry, Hugo Boss, Davidoff, and Calvin Klein.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S0.40
P/FCF7.51
EV/EBITDA
EV/Sales0.91
Graham №

Profitability

Gross 63.2%
Operating -10.3%
Net -9.2%
FCF 5.4%
ROE / ROIC -15.4% · -8.6%

Financial Health

Current ratio0.82
Quick ratio0.49
Debt / equity1.03
Debt / EBITDA
Net cash −$2.91B
Working capital−$420.80M

Cash Flow · TTM

Operating CF $505.00M
Capex −$194.50M
Free cash flow $310.50M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

4 / 9
Middling fundamentals · 4 of 9 signals passing

Altman Z-Score

-0.3
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings